We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Common Anti-fungal Drug Considered for Use in Cystic Fibrosis

News   Mar 13, 2019 | by Molly Campbell, Science Writer, Technology Networks

 
Common Anti-fungal Drug Considered for Use in Cystic Fibrosis

In people with cystic fibrosis, a protein that releases bicarbonate, a key infection-fighting agent (represented by red spheres), is missing or defective (brown ribbon structure). The drug amphotericin (white structure) can form channels to release bicarbonate in lung tissue. Credit: Rebecca Schultz, Carle Illinois College of Medicine

 
 
Advertisement
 

RELATED ARTICLES

Biochemical Pathway Discovered That Protects Cells From Ferroptosis

News

In an article published in Cell Metabolism, Moffitt Cancer Center researchers report on a newly discovered biochemical pathway that protects cells from a type of cell death called ferroptosis.

READ MORE

Test Can Quickly Identify Pneumonia in Patients With Severe COVID-19

News

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

READ MORE

Drug May Reduce Tumor Volume in Neurofibromatosis

News

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE